Old Web
English
Sign In
Acemap
>
Paper
>
Prognostic and Immune-Related Factors for Response to Duvelisib in the Phase 2 DYNAMO TM Clinical Trial in iNHL
Prognostic and Immune-Related Factors for Response to Duvelisib in the Phase 2 DYNAMO TM Clinical Trial in iNHL
2018
Pier Luigi Zinzani
Ian W. Flinn
Carole B. Miller
Scott A. Tetreault
Kirit M Ardeshna
Ngocdiep T. Le
Jonathan A. Pachter
Kam Sprott
Stephanie Lustgarten
David T. Weaver
Nina D. Wagner-Johnston
Keywords:
Clinical trial
Immune system
Oncology
Duvelisib
Internal medicine
Medicine
Dynamo
Surrogate endpoint
Neutropenia
Follicular lymphoma
Immunology
related factors
Adverse effect
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]